Applying 3D-FRAP microscopy to analyse gap junction-dependent shuttling of small antisense RNAs between cardiomyocytes.

Small antisense RNAs like miRNA and siRNA are of crucial importance in cardiac physiology, pathology and, moreover, can be applied as therapeutic agents for the treatment of cardiovascular diseases. Identification of novel strategies for miRNA/siRNA therapy requires a comprehensive understanding of the underlying mechanisms. Emerging data suggest that small RNAs are transferred between cells via gap junctions and provoke gene regulatory effects in the recipient cell. To elucidate the role of miRNA/siRNA as signalling molecules, suitable tools are required that will allow the analysis of these small RNAs at the cellular level. In the present study, we applied 3 dimensional fluorescence recovery after photo bleaching microscopy (3D-FRAP) to visualise and quantify the gap junctional exchange of small RNAs between neonatal cardiomyocytes in real time. Cardiomyocytes were transfected with labelled miRNA and subjected to FRAP microscopy. Interestingly, we observed recovery rates of 21% already after 13min, indicating strong intercellular shuttling of miRNA, which was significantly reduced when connexin43 was knocked down. Flow cytometry analysis confirmed our FRAP results. Furthermore, using an EGFP/siRNA reporter construct we demonstrated that the intercellular transfer does not affect proper functioning of small RNAs, leading to marker gene silencing in the recipient cell. Our results show that 3D-FRAP microscopy is a straightforward, non-invasive live cell imaging technique to evaluate the GJ-dependent shuttling of small RNAs with high spatio-temporal resolution. Moreover, the data obtained by 3D-FRAP confirm a novel pathway of intercellular gene regulation where small RNAs act as signalling molecules within the intercellular network.

[1]  J. Nitsche,et al.  The permeability of gap junction channels to probes of different size is dependent on connexin composition and permeant-pore affinities. , 2004, Biophysical journal.

[2]  B. Patel,et al.  Therapeutic implications of small interfering RNA in cardiovascular diseases , 2013, Fundamental & clinical pharmacology.

[3]  R. David,et al.  Gap junctional shuttling of miRNA--A novel pathway of intercellular gene regulation and its prospects in clinical application. , 2015, Cellular signalling.

[4]  M. Maes,et al.  Connexin and pannexin signaling in gastrointestinal and liver disease. , 2015, Translational research : the journal of laboratory and clinical medicine.

[5]  D. Catalucci,et al.  MicroRNA-1 Downregulation Increases Connexin 43 Displacement and Induces Ventricular Tachyarrhythmias in Rodent Hypertrophic Hearts , 2013, PloS one.

[6]  Michael D. Schneider,et al.  The Quest for the Adult Cardiac Stem Cell. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[7]  A. Kleber,et al.  Relative Contributions of Connexins 40 and 43 to Atrial Impulse Propagation in Synthetic Strands of Neonatal and Fetal Murine Cardiomyocytes , 2006, Circulation research.

[8]  J. Sluijter MicroRNAs in Cardiovascular Regenerative Medicine: Directing Tissue Repair and Cellular Differentiation , 2013 .

[9]  J. Ai,et al.  MicroRNA-23a Participates in Estrogen Deficiency Induced Gap Junction Remodeling of Rats by Targeting GJA1 , 2015, International journal of biological sciences.

[10]  D. Grimm Small silencing RNAs: state-of-the-art. , 2009, Advanced drug delivery reviews.

[11]  Clarence Yapp,et al.  Functional assessment of gap junctions in monolayer and three-dimensional cultures of human tendon cells using fluorescence recovery after photobleaching , 2014, Journal of biomedical optics.

[12]  P. Michela,et al.  Role of connexin 43 in cardiovascular diseases. , 2015, European journal of pharmacology.

[13]  Meng Li,et al.  Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases , 2015, BioMed research international.

[14]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[15]  Baohong Zhang,et al.  Translational Medicine: microRNAs: a new emerging class of players for disease diagnostics and gene therapy , 2008 .

[16]  Steven S. Scherer,et al.  Dominant connexin26 mutants associated with human hearing loss have trans-dominant effects on connexin30 , 2010, Neurobiology of Disease.

[17]  Heiko Lemcke,et al.  Neuronal differentiation requires a biphasic modulation of gap junctional intercellular communication caused by dynamic changes of connexin43 expression , 2013, The European journal of neuroscience.

[18]  E. Wolvetang,et al.  Gap junction mediated transport of shRNA between human embryonic stem cells. , 2007, Biochemical and biophysical research communications.

[19]  M. Rosen,et al.  Connexin‐specific cell‐to‐cell transfer of short interfering RNA by gap junctions , 2005, The Journal of physiology.

[20]  E. Ehler,et al.  Establishment of cardiac cytoarchitecture in the developing mouse heart. , 2006, Developmental biology.

[21]  Gene Kim,et al.  Downregulation of connexin43 by microRNA-130a in cardiomyocytes results in cardiac arrhythmias. , 2014, Journal of molecular and cellular cardiology.

[22]  C. Naus,et al.  Gap junctions modulate glioma invasion by direct transfer of microRNA , 2015, Oncotarget.

[23]  Gerard Pasterkamp,et al.  Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. , 2010, Stem cell research.

[24]  F. Guillemin,et al.  Gap junctional intercellular communication capacity by gap‐FRAP technique: A comparative study , 2007, Biotechnology journal.

[25]  T. Thum,et al.  MicroRNAs in Myocardial Infarction , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[26]  T. Mikkelsen,et al.  Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal , 2013, Oncotarget.

[27]  A comparison of two cellular delivery mechanisms for small interfering RNA , 2015, Physiological reports.

[28]  D. Lio,et al.  Are Endothelial Progenitor Cells the Real Solution for Cardiovascular Diseases? Focus on Controversies and Perspectives , 2015, BioMed research international.

[29]  P. Brink,et al.  Cardiac Gap Junction Channels Show Quantitative Differences in Selectivity , 2002, Circulation research.

[30]  S. Scherer,et al.  Human connexin26 and connexin30 form functional heteromeric and heterotypic channels. , 2007, American journal of physiology. Cell physiology.

[31]  Marcello Rota,et al.  Human Cardiac Stem Cell Differentiation Is Regulated by a Mircrine Mechanism , 2011, Circulation.

[32]  C. Naus,et al.  Implications and challenges of connexin connections to cancer , 2010, Nature Reviews Cancer.

[33]  Tomitake Tsukihara,et al.  Structure of the gap junction channel and its implications for its biological functions , 2011, Cellular and Molecular Life Sciences.

[34]  M. Latronico,et al.  microRNAs in cardiovascular diseases: current knowledge and the road ahead. , 2014, Journal of the American College of Cardiology.

[35]  E. Sontheimer,et al.  Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.

[36]  E. Olson,et al.  Inhibition of miR-15 Protects Against Cardiac Ischemic Injury , 2012, Circulation research.

[37]  T. Liang,et al.  Gap Junctions Enhance the Antiproliferative Effect of MicroRNA‐124‐3p in Glioblastoma Cells , 2015, Journal of cellular physiology.

[38]  J. Uney,et al.  Connexin 36 Expression Regulates Neuronal Differentiation from Neural Progenitor Cells , 2011, PloS one.

[39]  M. Chopp,et al.  Functional microRNA is transferred between glioma cells. , 2010, Cancer research.

[40]  James W. Smyth,et al.  Actin Cytoskeleton Rest Stops Regulate Anterograde Traffic of Connexin 43 Vesicles to the Plasma Membrane , 2012, Circulation research.

[41]  Steven J. Greco,et al.  Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. , 2011, Cancer research.

[42]  Michael D. Schneider,et al.  Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure , 2008, Proceedings of the National Academy of Sciences.